Prescription drugs can switch over to over-the-counter status when patents expire, but in order for this switch process to be seamless, productive and clinically safe — and to gain market share — there needs to be a successful process in place. Additionally, when switching an RX to an OTC, you need to evaluate the regulatory environment and commercial outcomes in order to determine if this is the right process for your drug.
The 2nd RX-to-OTC Switch Summit will allow you to network with colleagues while exploring the switch process from beginning to end. Whether you are playing with the idea of tapping into the very lucrative OTC marketplace or are an expert in the field, this conference assesses the current switch landscape in the US and beyond. It also provides a comprehensive overview of marketing trends, cutting-edge technology and regulatory developments, and is a forum for discussing lessons learned from past switches.
This conference is designed for pharmaceutical, biotechnology and consumer health professionals with responsibilities in an array of areas, including:
“Brought up some new points that I did not think of previously.”
—Senior Director of Regulatory Affairs, PERRIGO
“Very clear, organized presentation skills, coupled with informative information.”
—Regulatory Consultant, ASTRAZENECA